Advertisement

Reactions Weekly

, Volume 1636, Issue 1, pp 8–8 | Cite as

Cisplatin feasible following carboplatin hypersensitivity

Clinical study
  • 29 Downloads

Reference

  1. Bergamini A, et al. Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin. Gynecologic Oncology 144: 72-76, No. 1, Jan 2017. Available from: URL: http://doi.org/10.1016/j.ygyno.2016.10.023 CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations